In a filing, Biohaven Ltd revealed its Director CHILDS JOHN W acquired Company’s shares for reported $8.0 million on Apr 22 ’24. In the deal valued at $41.00 per share,195,121 shares were bought. As a result of this transaction, CHILDS JOHN W now holds 4,096,512 shares worth roughly $162.26 million.
Then, Coric Vlad bought 121,951 shares, generating $4,999,991 in total proceeds. Upon buying the shares at $41.00, the Chief Executive Officer now owns 1,788,417 shares.
Before that, Bailey Gregory bought 48,780 shares. Biohaven Ltd shares valued at $1,999,980 were divested by the Director at a price of $41.00 per share. As a result of the transaction, Bailey Gregory now holds 1,574,568 shares, worth roughly $62.37 million.
RBC Capital Mkts initiated its Biohaven Ltd [BHVN] rating to an Outperform in a research note published on February 16, 2024; the price target was $62. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. H.C. Wainwright began covering BHVN with “Buy” recommendation on December 22, 2023. Robert W. Baird started covering the stock on December 08, 2023. It rated BHVN as “an Outperform”.
Price Performance Review of BHVN
On Tuesday, Biohaven Ltd [NYSE:BHVN] saw its stock jump 3.34% to $39.61. Over the last five days, the stock has lost -9.50%. Biohaven Ltd shares have fallen nearly -7.45% since the year began. Nevertheless, the stocks have risen 176.22% over the past one year. While a 52-week high of $62.21 was reached on 03/08/24, a 52-week low of $12.35 was recorded on 04/19/24. SMA at 50 days reached $51.31, while 200 days put it at $35.05. A total of 2.09 million shares were traded, compared to the trading of 1.13 million shares in the previous session.
Levels Of Support And Resistance For BHVN Stock
The 24-hour chart illustrates a support level at 38.61, which if violated will result in even more drops to 37.62. On the upside, there is a resistance level at 41.24. A further resistance level may holdings at 42.88. The Relative Strength Index (RSI) on the 14-day chart is 28.99, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -7.99, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.96%. Stochastics %K at 7.55% indicates the stock is a buying.
The most recent change occurred on January 24, 2023 when SVB Securities began covering the stock and recommended ‘”an Outperform”‘ rating along with a $24 price target.
